From development to market ABL Europe provides GMP viral vectors, contributing to the success of our clients’ immunotherapy innovations. 

ABL Europe SAS is a pure-play GMP CMO licensed in accordance with EMA, completely dedicated to the provision of viral vector GMP contract manufacturing services, and a subsidiary of ABL Inc. under the corporate ownership of Institut Mérieux. ABL has a strong technical & regulatory track record in process development, scale-up & GMP manufacturing of filterable & non-sterile filterable (aseptic processing) viral vectors used in all phases of clinical development globally. With different adherent platforms (< 60 m2) and suspension (< 500 L) capabilities for drug substance and drug product (< 10,000 vials per batch) in-house, experience in process characterisation and validation, ABL provides its clients with a long-term strategic manufacturing option through clinical development & licensure for a range of virus vector gene therapy & vaccine products. ABL Europe’s clients are located worldwide.

Biotechnology

Life Sciences

Therapeutics

ABL's headquarters in Illkirch-Graffenstaden (Strasbourg), France

This department focuses on overseeing and managing maintenance and new works activities.

Maintenance Operations

The Quality Assurance and Control team at ABL ensures the highest standards of quality and compliance throughout the production process of GMP viral vectors. They are responsible for monitoring and testing products, implementing quality management systems, and conducting audits to guarantee that all manufacturing activities adhere to regulatory guidelines. This team plays a critical role in fostering product integrity and reliability, supporting ABL’s mission to facilitate successful immunotherapy innovations for clients worldwide.

Quality Assurance and Control

The Scientific Research and Development team at ABL Europe focuses on advancing the development and optimization of GMP viral vector manufacturing processes. This multidisciplinary team employs cutting-edge scientific methodologies to enhance production efficiency, ensure regulatory compliance, and support the successful transition of clients' immunotherapy projects from development to clinical application. By integrating process development and analytical expertise, the team aims to deliver innovative solutions that align with industry standards and client needs.

Scientific Research and Development

The Production and Manufacturing team at ABL Europe is responsible for the large-scale production and processing of GMP viral vectors. This team oversees the entire manufacturing process, from upstream to downstream operations, ensuring compliance with regulatory standards and maintaining high-quality output. With a focus on efficiency and innovation, they support clients in the development of cutting-edge immunotherapy solutions, playing a crucial role in advancing clinical trials and licensure of gene therapy and vaccine products.

Production and Manufacturing

This department focuses on the production and development processes within bioproduction.

People (2)

Jobs (0)

Other teams

Quality Assurance and Control

Scientific Research and Development

Production and Manufacturing

Bioproduction Operations